Niowave to expand in Michigan, driving $20M investment and creating 35 high-paying jobs in life sciences and tech industry
Niowave Inc, a global producer of medical isotopes, has announced plans to expand in Lansing, Michigan, which will drive $20 million in investment and create 35 good-paying jobs in the life sciences and tech industry. The project is supported by a $500,000 Jobs Ready Michigan Program performance-based grant. Niowave is one of the few companies worldwide that can design, build, test and operate superconducting linear accelerators in their own facility.
Niowave was established in 2005 as a spinoff from the National Superconducting Cyclotron Lab, the laboratory now known as Facility for Rare Isotope Beams (FRIB), which the MEDC supported in February 2014 and officially opened in May 2022. Niowave supplies medical and industrial radioisotopes produced from uranium and radium.
The company chose Michigan for the project over competing sites in California, Indiana, South Carolina, and Tennessee to take advantage of the regional talent pool that combines the advanced manufacturing heritage and the number one-rated nuclear physics program at Michigan State University. The company plans to grow at its existing facility in Lansing near the Capital Region International Airport, where it will expand production of several medical radioisotopes used in diagnostic and therapeutic treatments. These isotopes enable the detection of life-threatening conditions such as cancer and heart disease for better patient outcomes.
Niowave currently ships cancer treatments from its Lansing facilities, and the expansion will allow for higher production of these important medical radioisotopes. The project will bring immediate, high-wage jobs in the tech and life sciences industries to the region and has the potential to make mid-Michigan an “isotope capital,” building on the work currently being done at the FRIB at Michigan State University.
Niowave’s expansion in Lansing is a testament to Michigan’s leadership in high tech and life sciences, as well as the strength of its business climate and talented workforce. MEDC Sr. Vice President of Regional Prosperity Matt McCauley stated that the project is a win for Lansing and for the entire state. Local officials, the Lansing Economic Area Partnership, and the Next Michigan Development Corporation are working to support the project, and Niowave intends, pending key local, state, and federal approvals that make the expansion possible, to proceed with the project later this year.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
